Medium-Term Business Plan
Vision 110 -Stage1-
FY2023-FY2025
Our vision to become “a company that contributes broadly to people's health by comprehensively developing healthcare-related businesses, with a core focus on the new drug business, which continuously provides high-value new drugs that meet medical needs”. We will strive to achieve this goal.